GSK obtains injunction in continuations case

In what must be viewed as a serious reverse for the USPTO, it looks like the pharma company GlaxoSmithKline has obtained an injunction preventing the implementation of the office’s new claims and continuations rules, which were due to come into…

Get unlimited access to all IAM content